首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1533589

神經血管設備市場規模、佔有率和成長分析：按產品、疾病病理學、工藝、治療用途和最終用途 - 行業預測，2024-2031 年

Neurovascular Devices Market Size, Share, Growth Analysis, By Product, By Disease Pathology(Aneurysm, Arteriovenous Malformation and Fistulas ), By Process, By Therapeutic Applications, By End-Use - Industry Forecast 2024-2031

出版日期: 2024年08月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球神經血管器械市場規模將為29億美元，從2023年的31.5億美元成長到2031年的60.4億美元，在預測期內（2024-2031年）預計複合年成長率為8.5%。

由於幾個關鍵因素，神經血管設備市場有望顯著成長。神經系統疾病的日益普及、技術的持續進步以及對微創手術的需求不斷增加是這種擴張的核心。此外，主要市場中神經系統疾病患者數量的增加導致對神經血管設備的需求增加。市場成長的主要催化劑是急性缺血性腦中風的高盛行率，這凸顯了對有效神經血管解決方案的需求。預計市場還將受益於產品核可以及採用先進技術的新產品發布的激增。然而，嚴格的法律規範，特別是美國FDA 的法規，確保這些設備符合嚴格的安全性和有效性標準，最終改善患者照護，儘管這會增加開發成本，從而提高品質。神經血管設備的持續技術創新，包括引入新型栓塞設備、血栓清除系統和先進的微導管，進一步推動了市場成長。美敦力 (Medtronic)、史賽克 (Stryker) 和 Penumbra 等領先公司正在透過尖端產品和技術進步推動市場發展。

市場概況
腦動脈瘤
- 栓塞彈簧圈
可拆裸線圈
塗層可拆線圈
- 流量轉換裝置
- 顱內支架
- 微導管
- 導管導引線
缺血性中風
- 血栓清除裝置
- 吸風/吸風裝置
- 血管勒除器
- 微導管
- 微導管導引線
- 球囊導管
頸動脈狹窄
- 頸動脈支架
- 栓塞防護裝置
- 球囊導管
動靜脈畸形和瘻管
- 液態栓塞劑
- 閉塞球囊導管
- 微導管
其他疾病

神經血管設備市場：依最終用戶分類

市場概況
醫院/手術中心
門診治療中心
實驗室/學術機構

按地區分類的神經血管設備市場規模

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Acandis GmbH（Germany）
Asahi Intecc Co. Ltd.（Japan）
Imperative Care Inc.（United States）
Integer Holdings Corporation（United States）
Johnson & Johnson（United States）
Medtronic plc（Ireland）
MicroPort Scientific Corporation（China）
Penumbra Inc.（United States）
Perflow Medical Ltd.（Israel）
Rapid Medical（Canada）
Stryker Corporation（United States）
Terumo Corporation（Japan）
WL Gore & Associates（United States）
Penumbra, Inc.（United States）（duplicate）
Silk Road Medical（United States）
Siemens Healthineers AG（Germany）
Le Maire Vascular（France）
Boston Scientific Corporation（United States）
Balt（Switzerland）
InspireMD, Inc.（Israel）

簡介目錄

Product Code: SQMIG35A2777

Global Neurovascular Devices Market size was valued at USD 2.90 Billion in 2022 and is poised to grow from USD 3.15 Billion in 2023 to USD 6.04 Billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).

The neurovascular devices market is set for significant growth, driven by several key factors. The rising incidence of neurological disorders, ongoing technological advancements, and the growing demand for minimally invasive procedures are central to this expansion. Additionally, the increasing number of patients suffering from neurological conditions in major markets has led to a heightened demand for neurovascular devices. A key catalyst for market growth is the high prevalence of acute ischemic stroke, which underscores the need for effective neurovascular solutions. The market is also expected to benefit from the surge in new product launches featuring advanced technologies, alongside rapid product approvals. However, the stringent regulatory frameworks, particularly the FDA regulations in the United States, ensure that these devices meet rigorous safety and efficacy standards, which can elevate development costs but ultimately enhance patient care quality. Continuous innovation in neurovascular devices, including the introduction of new embolization devices, thrombectomy systems, and advanced microcatheters, is further fueling market growth. Leading companies like Medtronic, Stryker, and Penumbra are at the forefront, driving the market with their cutting-edge products and technological advancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurovascular Devices Market Segmental Analysis

The Neurovascular Devices Market is segmented into Disease Pathology, End-User and Region. Based on Disease Pathology, the market is segmented into Cerebral Aneurysm (Embolic Coils [Bare Detachable Coils, Coated Detachable Coils], Flow Diversion Devices, Intracranial Stents, Microcatheters, Guidewires), Arteriovenous Malformation And Fistulas (Liquid Embolic Agents, Occlusion Balloon Catheters, Microcatheters), Ischemic Stroke (Clot Retriever Devices, Suction & Aspiration Devices, Vascular Snares, Microcatheters, Micro Guidewires, Balloon Catheters), Carotid Artery Stenosis (Carotid Artery Stents, Embolic Protection Devices, Balloon Catheters), and Others. Based on End-User, the market is trifurcated into, Hospitals and Surgical Centers, Ambulatory Care Centers, Research Laboratories and Academic Institutes. Based on Region the market is segmented as, North America, Europe, Asia-Pacific, LAMEA, and the Middle East and Africa.

Drivers of the Global Neurovascular Devices Market

The growing preference for minimally invasive surgeries is largely due to their significant benefits, such as lower risks and reduced trauma compared to traditional procedures. These surgeries involve smaller incisions, which lead to less postoperative pain and quicker recovery times. This has significantly driven the adoption of minimally invasive techniques and spurred extensive research and development efforts in the field. Leading industry players are investing heavily in developing innovative surgical instruments to advance minimally invasive procedures.

Restraints in the Global Neurovascular Devices Market

Integrating new neurovascular devices into existing medical infrastructure can be challenging and time-consuming. Often, these devices are not fully compatible with current equipment and electronic health record (EHR) systems used in many hospitals. This integration challenge requires substantial time and resources, potentially delaying the deployment of new technologies and increasing costs.

Market Trends of the Global Neurovascular Devices Market

Globally, the rise in minimally invasive surgeries is driven by their aesthetic benefits, such as shorter recovery times, which is expected to further boost the neurovascular devices market. This growth is largely attributed to advancements in innovation and ongoing improvements within surgical techniques, aimed at enhancing patient safety. Developments in laparoscopic and endoscopic procedures, as well as the introduction of robotic surgeries, signify a shift towards more sophisticated techniques. This trend creates a favorable market environment conducive to the continued progress of the neurovascular devices industry.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Case Study Analysis
Pricing Analysis
Value Chain Analysis
Patent Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Ecosystem of the Market
Start-up Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Global Neurovascular Devices Market by Disease Pathology

Market Overview
Cerebral aneurysms
- Embolic coils
Bare detachable coils
Coated detachable coils
- Flow diversion devices
- Intracranial stents
- Microcatheters
- Guidewires
Ischemic strokes
- Clot retriever devices
- Suction & aspiration devices
- Vascular snares
- Microcatheters
- Micro guidewires
- Balloon catheters
Carotid artery stenosis
- Carotid artery stents
- Embolic protection devices
- Balloon catheters
Arteriovenous malformation & fistulas
- Liquid embolic agents
- Occlusion balloon catheters
- Microcatheters
Other disease pathologies

Global Neurovascular Devices Market by End-user

Market Overview
Hospitals and surgical centres
Ambulatory care centres
Research laboratories and academic institutes

Global Neurovascular Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Acandis GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imperative Care Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perflow Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rapid Medical (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WL Gore & Associates (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States) (duplicate)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Silk Road Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Le Maire Vascular (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InspireMD, Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments